Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib.
作者信息
Abdelrahman R A, Begna K H, Al-Kali A, Hogan W J, Litzow M R, Tefferi A
机构信息
Division of Hematology and Department of Medicine, Mayo Clinic, Rochester, MN, USA.
出版信息
Leukemia. 2015 Feb;29(2):498-500. doi: 10.1038/leu.2014.286. Epub 2014 Sep 25.
PMID:25252872
Abstract
摘要
Zotero 插件